Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Out-licensing

Patented Skin Care Technology Available For Licensing In North America

Swedish Skin Care, Inc.
Licensing opportunities in Rx, OTC and Cosmeceutical arenas

Mechanism of action

Liquid composition with trans-dermal delivery system.

Full description

Our novel technology has demonstrated accelerated healing capabilities and is remarkably effective in treating 1st degree burns, including sunburn (and 2nd degree burns in some cases), shaving and waxing irritations in women, shaving irritations in men, pruritus of various ethiologies and cold sores.

The technology has also shown to be effective in treating fungus, skin wounds (surgical scarring, cuts, abrasions and lacerations), psoriasis and insect bites.

Patent information

U.S. Patent 6,096,326.

Patent protection filed in Canada. Swedish Skin Care expects a Canadian patent to be issued eminently.

Type of business relationship sought

Swedish Skin Care seeks like-minded, forward-thinking, suitable licensing partners in the Rx, OTC and cosmeceutical arenas, whose strategy is to introduce new high-performance products under patent protection at a fraction of the normal time, costs and risks associated with traditional product launches.

Effective target applications are numerous and range from enhanced healing and functional/performance benefits for various skin conditions, diseases and concerns in OTC and Rx markets, to multiple benefits in consumer care markets.

Target applications of the technology available for immediate licensing include: 1st degree burns (including sunburn) with possibilities of 2nd degree burns, various anti-itch applications, shaving irritation treatments for women and men (razor burn, razor bumps, ingrown hairs, redness, inflammation and discomfort), post-waxing irritation treatments, cold sores, wound healing (post surgical scarring, cuts and lacerations), anti-fungus applications and psoriasis.

The technology is presently licensed in the U.S. indoor tanning industry.

Partnering consultation free of charge
Pharmalicensing Jobs 1
Maximizing Pharmaceutical Patent Lifecycles
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us